id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0152-0009,FDA,FDA-2011-E-0152,"U.S. Patent and Trademark Office to Dainippono Sumitomo Pharma Co., Ltd. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP)  - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T15:05:23Z,,0,0,09000064812bdd53
FDA-2011-E-0152-0008,FDA,FDA-2011-E-0152,Notice of Final Determination - Letter,Other,Letter(s),2013-03-15T04:00:00Z,2013,3,2013-03-15T04:00:00Z,,2013-03-15T13:44:39Z,,0,0,090000648122cf55
FDA-2011-E-0152-0007,FDA,FDA-2011-E-0152,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T18:17:27Z,,0,0,090000648119c9b4
FDA-2011-E-0152-0006,FDA,FDA-2011-E-0152,Determination of Regulatory Review Periods for Patent Extension: LATUDA,Notice,General Notice,2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,2012-05-06T03:59:59Z,2012-04-06T13:20:23Z,2012-08354,0,0,0900006480feaa50
FDA-2011-E-0152-0005,FDA,FDA-2011-E-0152,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-03T04:00:00Z,2012,4,2012-04-03T04:00:00Z,,2012-04-03T19:23:34Z,,0,0,0900006480fe7bb7
FDA-2011-E-0152-0004,FDA,FDA-2011-E-0152,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2011-09-16T04:00:00Z,2011,9,2011-09-16T04:00:00Z,,2011-09-16T14:33:42Z,,0,0,0900006480f1f1b4
FDA-2011-E-0152-0003,FDA,FDA-2011-E-0152,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-04-26T04:00:00Z,2011,4,2011-04-26T04:00:00Z,,2011-04-26T19:10:44Z,,0,0,0900006480c39e20
FDA-2011-E-0152-0001,FDA,FDA-2011-E-0152,"Dainippono Sumitomo Pharma Co., Ltd. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP) Patent Extension Application",Other,APP-Application,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-08-11T03:13:34Z,,0,0,0900006480c050b0
FDA-2011-E-0152-0002,FDA,FDA-2011-E-0152,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-03-10T05:00:00Z,2011,3,2011-03-10T05:00:00Z,,2013-07-27T23:47:03Z,,0,0,0900006480c04c39